U.S. Food Stock News

NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian Automotive (RIVN) Is Down 6.4% After Delaying Launch Of Its Lowest-Priced R2 SUV

Earlier this month, Rivian Automotive announced full trims and pricing for its new R2 mid-size electric SUV, with Performance models starting at US$57,990 in spring 2026 and lower-priced Premium and Standard variants rolling out through 2027. A key detail is that the widely anticipated approximately US$45,000 entry-level R2 will not arrive until late 2027, reshaping expectations for how quickly Rivian can reach more price-sensitive, mass-market buyers. We’ll now examine how the delayed...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

A Look At Jack Henry & Associates (JKHY) Valuation After Recent Results Dividend Growth And Product Momentum

Jack Henry & Associates (JKHY) is back in focus after its Financial Crimes Defender platform was added to the Independent Community Bankers of America Preferred Service Provider program, highlighting its role in fraud prevention for community banks. See our latest analysis for Jack Henry & Associates. At a latest share price of $168.77, Jack Henry & Associates has seen a 7.71% 1 month share price return but a 10.06% 3 month share price decline. Its 5 year total shareholder return of 21.27%...
NYSE:PII
NYSE:PIILeisure

Assessing Polaris (PII) Valuation After Russell 1000 Inclusion And Indian Brand Sale Plan

Interest in Polaris (PII) has picked up after its addition to the Russell 1000 ETF, along with plans to sell its Indian motorcycle brand to Carolwood and fresh coverage from Wells Fargo. See our latest analysis for Polaris. Despite the latest headlines, momentum in Polaris stock has cooled, with a 30-day share price return of 23.38% and a year to date share price return of 24.14%, even as the 1-year total shareholder return stands at 25.31%. Recent attention around its Russell 1000 inclusion,...
NYSE:CCI
NYSE:CCISpecialized REITs

A Look At Crown Castle (CCI) Valuation After Earnings Beat And Planned Small Cell And Fiber Divestiture

Crown Castle (CCI) is back in focus after Q4 2025 earnings topped expectations, with EPS of $0.67 and revenue of $1.07b, alongside plans to sell its small cell and fiber divisions. See our latest analysis for Crown Castle. The Q4 earnings beat and the plan to sell small cell and fiber assets come after a patchy stretch. The 30 day share price return is a 3.22% decline, and the 1 year total shareholder return is an 11.27% decline, suggesting recent enthusiasm is emerging from a weaker long...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen TrumpRx Discounts Put Drug Pricing And Growth Story In Focus

Amgen has partnered with the government run TrumpRx platform to offer deep discounts on key brand name drugs. The agreement covers major products such as Amjevita, Aimovig, and Repatha as part of a broader U.S. drug pricing initiative. The move links Amgen directly to the Most Favored Nation pricing effort aimed at improving drug affordability and access. For investors watching NasdaqGS:AMGN, this development comes with the stock trading around $366.21 and showing a 20.4% return over the...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Is Sunrun’s (RUN) Battery Storage Dominance Offsetting Concerns About Softer Near-Term Earnings?

In recent days, Sunrun reported softer expectations for near-term earnings as analysts cut forecasts and voiced concern about slower solar origination and capacity deployment, even while revenue is still expected to grow. At the same time, Sunrun remains a major force in U.S. residential battery storage, controlling roughly half of 2025 installations and about 44% of national residential storage capacity, highlighting a tension between operational leadership and financial strain. Now we’ll...
NasdaqCM:DNTH
NasdaqCM:DNTHBiotechs

Dianthus Therapeutics (DNTH) Is Up 19.4% After Early CAPTIVATE GO Decision And $719M Raise

Dianthus Therapeutics recently reported an early GO decision in its Phase 3 CAPTIVATE trial of claseprubart for CIDP, after achieving 20 confirmed responders ahead of the planned interim analysis and confirming a favorable safety profile through independent DSMB review. On the heels of these clinical results, the company completed a large follow-on public equity offering of common stock and pre-funded warrants, raising roughly US$719,000,000 to support ongoing trials, commercial readiness,...
NYSE:BWA
NYSE:BWAAuto Components

Assessing BorgWarner (BWA) Valuation After A Mixed Stretch Of Share Price Returns

What Recent Returns Say About BorgWarner BorgWarner (BWA) has drawn investor attention after a mixed run in its share price, with a recent month decline contrasting with gains over the past 3 months, year to date, and the past year. That backdrop, alongside annual revenue of about US$14.3b and net income of US$277 million, sets the stage for a closer look at how the auto technology supplier’s current valuation compares with its recent performance. See our latest analysis for BorgWarner. At...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Does UAE Thalassemia Approval for PYRUKYND Reframe the Bull Case for Agios Pharmaceuticals (AGIO)?

In March 2026, Agios Pharmaceuticals announced that the Emirates Drug Establishment approved PYRUKYND (mitapivat) as the only authorized treatment in the UAE for adult patients with both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, expanding its reach in the Gulf region via its NewBridge Pharmaceuticals partnership. This approval deepens Agios’s footprint in rare hematologic diseases across the Gulf Cooperation Council, reinforcing the importance of...
NYSE:SAH
NYSE:SAHSpecialty Retail

Assessing Sonic Automotive (SAH) Valuation After Recent Share Weakness And EchoPark Growth Expectations

Event context and recent share performance Sonic Automotive (SAH) has drawn investor attention after a period of mixed share performance, with the stock down about 1% over the past week and roughly 9% over the past 3 months. See our latest analysis for Sonic Automotive. At a share price of $59.89, Sonic Automotive’s recent 1 day and 90 day share price declines of 1.32% and 8.8% contrast with a 1 year total shareholder return of 4.01%. This suggests that short term momentum has cooled while...
BATS:CBOE
BATS:CBOECapital Markets

How Investors Are Reacting To Cboe Global Markets (CBOE) Extending VIX Tools Into Bitcoin And Prediction Markets

Cboe Global Markets, Inc. has announced plans to launch the Cboe IBIT Volatility Index and a new prediction markets framework, extending its VIX methodology into bitcoin and introducing three-outcome, fixed-return contracts initially tied to Mini S&P 500 Index prediction markets. By pairing a bitcoin volatility gauge with an options-style prediction market that allows partial payouts, Cboe is seeking to broaden access to outcome-based trading while aligning it with established exchange...
NYSE:GWRE
NYSE:GWRESoftware

The Bull Case For Guidewire Software (GWRE) Could Change Following Strong Quarter And Cloud Wins – Learn Why

In March 2026, Guidewire Software reported quarterly results showing revenue of US$359.1 million and net income of US$60.11 million, alongside higher full-year guidance and accelerating annual recurring revenue growth. A key client, IAG New Zealand, also migrated its on-premises ClaimCenter system to the Guidewire Cloud Platform, underscoring growing adoption of Guidewire’s cloud-based insurance solutions. Next, we’ll explore how Guidewire’s stronger guidance and accelerating cloud...
NYSE:BFH
NYSE:BFHConsumer Finance

How Investors May Respond To Bread Financial (BFH) Partnering With Ford On Co‑Branded Card And Loans

In March 2026, Ford Motor Company announced a long-term agreement with Bread Financial to launch a co-branded Ford Rewards Visa Signature credit card and integrated installment loan program, giving Ford customers flexible financing and reward-earning options across online channels and dealerships nationwide. A distinctive aspect of this partnership is Bread Financial’s planned use of data-driven insights with Ford to refine offers and experiences across multiple customer touchpoints,...
NasdaqGM:TRVI
NasdaqGM:TRVIPharmaceuticals

Assessing Trevi Therapeutics (TRVI) Valuation After FDA Alignment On Phase 3 IPF Chronic Cough Program

Trevi Therapeutics (TRVI) has secured FDA alignment on its clinical plan for nalbuphine ER in IPF related chronic cough, clearing the way for two randomized, double blind, placebo controlled Phase 3 trials starting later this year. See our latest analysis for Trevi Therapeutics. That FDA alignment comes after a recent pullback, with a 7 day share price return showing a decline of 17.22% and a 90 day share price return showing a decline of 12.69%. However, the 1 year total shareholder return...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

A Look At Check Point Software Technologies (CHKP) Valuation After Recent Share Price Weakness

Check Point Software Technologies (CHKP) has been on some investors’ radar after a mixed picture in recent returns, with the stock down over the past year while still showing positive multi year total returns. See our latest analysis for Check Point Software Technologies. At a share price of US$153.65, Check Point’s recent 7 day share price return of 7% and 30 day return of 10.4% cap a weaker spell, which contrasts with its positive 3 and 5 year total shareholder returns. This suggests longer...
NYSE:KOF
NYSE:KOFBeverage

Coca-Cola FEMSA (NYSE:KOF) Valuation Check After Recent Pullback And 10.2% Estimated Discount

Coca-Cola FEMSA. de (NYSE:KOF) is back on investor radars after recent trading left the shares with a mixed return profile, including a 2.2% decline over the past day and 6.8% over the past week. See our latest analysis for Coca-Cola FEMSA. de. The recent 1-month share price return of a 13.8% decline contrasts with Coca-Cola FEMSA. de’s 90-day share price return of 3.5% and 1-year total shareholder return of 13.6%. This suggests shorter term momentum has cooled, while longer term holders have...
NYSE:SCHW
NYSE:SCHWCapital Markets

How Investors May Respond To Charles Schwab (SCHW) Strong February Inflows, New Accounts and Revenue Outlook

In February 2026, Charles Schwab reported core net new assets of US$32.50 billion and a 9% year-over-year rise in 395,000 new brokerage accounts, alongside updated revenue guidance pointing to faster first-quarter revenue growth. Together with Schwab’s finalized acquisition of Forge Global to expand access to private markets, these figures highlight how the firm is broadening its investing platform while deepening client engagement. We’ll now examine how Schwab’s stronger February asset...
NasdaqGS:AEP
NasdaqGS:AEPElectric Utilities

How Investors Are Reacting To American Electric Power (AEP) Leadership Shift And $750 Million Texas Debt Raise

American Electric Power has appointed Adrian Rodriguez as president and chief operating officer of AEP Texas, following Judith Talavera’s departure, as the subsidiary continues to support approximately 1,094,000 Texas customers and taps the bond market with a US$750 million senior notes issuance due 2036. Rodriguez’s extensive regulatory and operational background in Texas and New Mexico could be important as AEP pursues long-term load growth from data centers and industrial customers across...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron Restructuring And Aphrodite Project Recast Capital Use And Valuation

Chevron (NYSE:CVX) is planning a company wide restructuring that includes a 15 to 20% reduction in its workforce. The company is also moving ahead with new engineering and procurement contracts for the Aphrodite Field offshore gas project in Cyprus with Worley. These steps indicate a shift in how Chevron allocates capital and manages projects following a period where broader sector and market themes attracted most of the attention. Chevron is one of the largest integrated energy companies,...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

A Look At iRhythm Holdings (IRTC) Valuation After Recent Share Price Weakness

Why iRhythm Holdings is on investors' radar today iRhythm Holdings (IRTC) has drawn attention after a recent stretch of weak share performance, with the stock showing negative returns over the past week, month and past 3 months. For investors, that pullback sits alongside positive annual revenue and net income growth, as well as a small positive 3 year total return and a higher 1 year total return. This combination is inviting a closer look at how the business is currently positioned. See our...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Xcel Energy (XEL) Valuation Check As Data Center Expansion And Grid Investment Plan Gain Traction

Xcel Energy (XEL) has drawn fresh attention after issuing US$800,000,000 of 5.75% junior subordinated notes due 2056, a long dated financing move that sits alongside reaffirmed earnings guidance and a large investment pipeline. See our latest analysis for Xcel Energy. At a share price of US$81.91, Xcel Energy has a 90 day share price return of 8.17% and a year to date share price return of 9.68%. Its 1 year total shareholder return of 21.15% and 5 year total shareholder return of 52.37%...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

A Look At Star Bulk Carriers (SBLK) Valuation As Management Prepares Capital Link Strategy Presentation

Star Bulk Carriers (SBLK) is drawing fresh attention as management prepares to outline its business outlook and growth plans in a Capital Link online presentation, following recent coverage of its steady earnings expectations. See our latest analysis for Star Bulk Carriers. At a share price of US$21.84, Star Bulk Carriers has seen a 7-day share price return of 7.69% decline and a 90-day share price return of 19.8%. Its 1-year total shareholder return of 35.14% and 5-year total shareholder...
NYSE:WT
NYSE:WTCapital Markets

Assessing WisdomTree (WT) Valuation After New Income Strategy And Adaptive Fund Launches

What WisdomTree’s New Product Lineup Means for Investors WisdomTree (WT) has been busy, rolling out the Halo-WisdomTree Structured Income Strategy with Halo Investing alongside two Nasdaq-listed adaptive moving average funds, WAMA and WIMA. These launches give investors new ways to approach equity exposure and income. See our latest analysis for WisdomTree. These product launches come as WisdomTree’s share price has climbed to US$15.26, with a 90 day share price return of 30.76% and a 1 year...
NYSE:CRS
NYSE:CRSAerospace & Defense

A Look At Carpenter Technology (CRS) Valuation After A Strong Multi Year Share Price Run

Carpenter Technology (CRS) has attracted fresh attention after recent price moves, with the stock closing at US$361.28. For investors, the bigger question is how that price lines up with recent performance. See our latest analysis for Carpenter Technology. The recent pullback, including a 4.2% 1 day share price decline and 6.7% 7 day share price return, comes after a strong run that has left the 1 year total shareholder return at 97.6% and the 5 year total shareholder return above 8x. If...